Services
Expertises
Resources
Who we are
Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 - Canada
Closed
Source verified July 23, 2026

Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024

Biopharmaceutical collaboration mission to Germany

Receipt of requests is now closed

Get notified about updates to this grant.

Funding available
Varies by project
Deadline
Closed
Location
Canada
Who can apply

Small and medium-sized enterprises.

See full eligibility

Overview

The Canadian biopharmaceuticals co-innovation mission to Germany takes place from November 3 to 8, 2024 and is open to small and medium-sized enterprises in the biopharmaceuticals sector. It focuses on collaboration in advanced therapies, drug delivery, antibody-based therapeutics, companion diagnostics, and biomanufacturing enabling technologies.
Receipt of requests is now closed
Get notified about updates to this grant.

At a glance

Funding available

Financing goals
  • Develop strategic partnerships
  • Conduct research and development activities
  • Access new markets
Eligible Funding
  • Varies by project

Eligible candidates

Eligible Industries
  • All industries
Location
  • Canada
Legal structures
  • For-profit business
Annual revenue
  • All revenue ranges
Organisation size
  • All organization sizes
Audience
  • All groups

Next Steps

1
Determine your project
2
Validate your eligibility

Official resources

Official page

Canadian biopharmaceuticals co-innovation mission to Germany - November 3 to 8, 2024

Eligibility

Who is eligible?

  • Small and medium-sized enterprises.

Additional information

  • The page is archived and will not be updated.
  • Related program: Canadian International Innovation Program.

Other components of this program

Explore related funding streams and grants that belong to the same program.

Frequently Asked Questions about the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 Program

What is the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024?

The Canadian biopharmaceuticals co-innovation mission to Germany takes place from November 3 to 8, 2024 and is open to small and medium-sized enterprises in the biopharmaceuticals sector. It focuses on collaboration in advanced therapies, drug delivery, antibody-based therapeutics, companion diagnostics, and biomanufacturing enabling technologies.

Who is eligible for the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 program?

To be eligible for the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 program, you must: Open to small and medium-sized enterprises.

Who can I contact for more information about the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024?

You can contact National Research Council Canada (NRC).

Where is the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 available?

The Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 program is available across Canada.

Is the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 a grant, loan, or tax credit?

Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 is a Partnering and Collaboration

Who are the financial supporters of the Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024?

Canadian biopharmaceuticals co-innovation mission to Germany – November 3 to 8, 2024 is funded by National Research Council Canada (NRC)